| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2002 | WO2002009718A2 Agents containing corticosteroids for reducing graft rejection reactions |
| 02/07/2002 | WO2002009716A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | WO2002009715A2 Use of an arylaldehyde 5-oxo-1, 2, 4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | WO2002009714A1 Compositions and methods for the treatment of anorectal disorders |
| 02/07/2002 | WO2002009712A1 Use of quinoline-2(1h)-one derivatives for treating renal disease |
| 02/07/2002 | WO2002009710A2 Paroxetine tablets and capsules |
| 02/07/2002 | WO2002009709A1 Method for reducing or eliminating smoking |
| 02/07/2002 | WO2002009708A1 Anti-angiogenic composition comprising ticlopidine and ginkgo biloba extract |
| 02/07/2002 | WO2002009707A1 Fentanyl composition for nasal administration |
| 02/07/2002 | WO2002009706A1 Agonists of follicle stimulating hormone activity |
| 02/07/2002 | WO2002009705A2 Agonist of follicle stimulating hormone activity |
| 02/07/2002 | WO2002009704A2 Pharmaceutical composition for transdermal delivery of befloxatone |
| 02/07/2002 | WO2002009703A1 Method for treating cryptorchidism |
| 02/07/2002 | WO2002009702A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 02/07/2002 | WO2002009701A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/07/2002 | WO2002009700A1 Cancer treatment by combination therapy |
| 02/07/2002 | WO2002009699A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 02/07/2002 | WO2002009698A1 Compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 02/07/2002 | WO2002009697A1 Highly purified simvastatin compositions |
| 02/07/2002 | WO2002009696A1 Methods for treating cell proliferative disorders and viral infections |
| 02/07/2002 | WO2002009695A1 Bimodal emulsions of taxanes and butyrate polyalcohol esters |
| 02/07/2002 | WO2002009694A1 Anticonvulsant derivatives useful for the treatment of depression |
| 02/07/2002 | WO2002009693A1 Method and compositions for prevention and/or treatment of diabetes and glucose modulation |
| 02/07/2002 | WO2002009692A1 Methods and compositions for the attenuation and/or prevention of stress/catabolic responses |
| 02/07/2002 | WO2002009691A1 Methods and compositions for the prevention and treatment of syndrome x |
| 02/07/2002 | WO2002009690A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | WO2002009689A1 Method for reducing exacerbations associated with copd |
| 02/07/2002 | WO2002009688A1 Fatty acid synthase inhibitors |
| 02/07/2002 | WO2002009687A1 Use of n-oleoylethanolamine for treating psoriasis |
| 02/07/2002 | WO2002009686A2 Cdc25 phosphatase inhibitors |
| 02/07/2002 | WO2002009684A2 Erbb-2 selective small molecule kinase inhibitors |
| 02/07/2002 | WO2002009683A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/07/2002 | WO2002009682A2 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 02/07/2002 | WO2002009681A2 A method for correcting the immune system of live body |
| 02/07/2002 | WO2002009680A2 Pharmacologically active substance for treating cardiovascular disorders |
| 02/07/2002 | WO2002009679A2 Use of 13-cis retinoic acid for the treatment of emphysema |
| 02/07/2002 | WO2002009678A2 Charged phospholipid compositions and methods for their use |
| 02/07/2002 | WO2002009677A2 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs |
| 02/07/2002 | WO2002009675A1 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release |
| 02/07/2002 | WO2002009667A2 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/07/2002 | WO2002009664A2 Use of a combination of active substances containing bioquinones for the production of cosmetic or dermatological preparations |
| 02/07/2002 | WO2002009651A2 Fatty acid synthase inhibitors |
| 02/07/2002 | WO2002009648A2 Antimicrobial biaryl compounds |
| 02/07/2002 | WO2002009643A2 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 02/07/2002 | WO2002009637A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/07/2002 | WO2002009631A1 Vaginal delivery of bisphosphonates |
| 02/07/2002 | WO2002009537A2 Alpha- (1, 4) linked glucose polymers containing oral compositions to alleviate or prevent tooth damage |
| 02/07/2002 | WO2002009524A1 A new antibacterial composition comprising as an active ingredient saponificated vegetable oil |
| 02/07/2002 | WO2001085700A3 Hiv replication inhibiting pyrimidines and triazines |
| 02/07/2002 | WO2001083439A3 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 02/07/2002 | WO2001081310A8 1-aroyl-piperidinyl benzamidines |
| 02/07/2002 | WO2001080813A3 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy |
| 02/07/2002 | WO2001078704A3 Gaba substrate and the use thereof for treating cognitive and emotional disorders |
| 02/07/2002 | WO2001074787A3 Crystalline pharmaceutical |
| 02/07/2002 | WO2001074395A3 Amiodarone-containing parenteral solution |
| 02/07/2002 | WO2001074343A3 Method for the treatment of dermal lesions caused by envenomation |
| 02/07/2002 | WO2001067890A3 Composition and method to treat weight gain and obesity attributable to psychotropic drugs |
| 02/07/2002 | WO2001066101A3 Treatment of psoriasis |
| 02/07/2002 | WO2001064937A3 Caspase-inhibitory-factor (cif) and uses thereof |
| 02/07/2002 | WO2001064238A3 Methods and compositions for regulating adipocytes |
| 02/07/2002 | WO2001062744A3 Substituted piperazine compounds |
| 02/07/2002 | WO2001060806A3 Substituted arylpyrazines |
| 02/07/2002 | WO2001058470A3 Methods for enhancing the bioavailability of a drug |
| 02/07/2002 | WO2001056959B1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 02/07/2002 | WO2001049663A3 Non-peptide inhibition of t-lymphocyte activation and therapies related thereto |
| 02/07/2002 | WO2001049297A8 Methods for inhibiting/treating hiv infections and aids related symptoms |
| 02/07/2002 | WO2001041747A3 Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating cancer |
| 02/07/2002 | WO2001035953A3 Exercise and muscle enhancement formulations |
| 02/07/2002 | WO2001035944A3 Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan |
| 02/07/2002 | WO2001035935B1 Inhibitors of endo-exonuclease activity such as pentamidine for the treatment of cancer |
| 02/07/2002 | WO2001032210A3 Compositions for treating atheroma and neoplastic tissue |
| 02/07/2002 | WO2001030333A3 Tissue factor antagonists and methods of use thereof |
| 02/07/2002 | WO2001028539A9 Agent for treating cephalic pain |
| 02/07/2002 | WO2001024781A3 Gene necessary for striatal function, uses thereof, and compounds for modulating same |
| 02/07/2002 | WO2001017479B1 Methods and compositions for preventing and treating prostate disorders |
| 02/07/2002 | WO2001013900A3 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 02/07/2002 | WO2001010425A3 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes |
| 02/07/2002 | WO2001007038A3 Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy |
| 02/07/2002 | WO2001000566A3 Substituted phenoxyacetic acids |
| 02/07/2002 | WO2000060117A3 Prediction of risk of interstitial lung disease |
| 02/07/2002 | WO2000032578A8 Benzimidazole compounds that are vitronectin receptor antagonists |
| 02/07/2002 | US20020016976 Mutant multi-substrate enzyme which accepts at least one orthogonal substrate analog, whereby catalytic activity results in combination of all or part of orthogonal substrate with other substrate of enzyme; drug screening |
| 02/07/2002 | US20020016625 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 02/07/2002 | US20020016616 Electro-medical device for use with biologics |
| 02/07/2002 | US20020016481 Oxireno-, azetidino-, and methano- picene derivatives |
| 02/07/2002 | US20020016471 Inhibitors of p38 |
| 02/07/2002 | US20020016467 Novel 4-diphenylmethyl piperdine derivatives |
| 02/07/2002 | US20020016465 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 02/07/2002 | US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics |
| 02/07/2002 | US20020016455 Epoxidation of cyclopenta(a)phenanthrene derivatives |
| 02/07/2002 | US20020016445 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 02/07/2002 | US20020016442 Hepatitis C inhibitor tri-peptides |
| 02/07/2002 | US20020016373 Adding to the fluoroether compound selected from evoflurane, enflurane, isoflurane, methoxyflurane and desflurane an effective stabilizing amount of a lewis acid inhibitor to prevent the degradation of fluoroether |
| 02/07/2002 | US20020016372 Method for preventing and treating alzheimer's disease and brain damage associated with cardiov ascular disease and head injury |
| 02/07/2002 | US20020016371 Exo-S-mecamylamine formulation and use in treatment |
| 02/07/2002 | US20020016370 A therapeutically effective amount of exo-R-mecamylamine or salt, substantially free of exo-S-mecamylamine in combination with a carrier; useful for treating substance addiction |
| 02/07/2002 | US20020016369 Administration to a patient suffering from psoriasis or psoriatic arthritis an effective amount of Nimesulide or its salt or a complex with cyclodextrin |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016364 Certain ethers of probucol, and their pharmaceutically acceptable salts or prodrugs, are useful for increasing circulating high density lipoprotein cholestrol |
| 02/07/2002 | US20020016362 Uses of diterpenoid triepoxides as an anti-proliferative agent |